Facebook
Instagram
Twitter
YouTube
Google Plus
RSS Feed
LinkedIn
Flickr
California's Stem Cell Agency
California Institute for Regenerative Medicine
For Researchers
Funding Opportunities
All Funding Opportunities
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
Grants
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
Clinical Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
Research Resources
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
2018 Annual Report
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Resolution Campaign
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
Annual Reports
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
Search form
Search
You are here
Home
› University of California, Davis
University of California, Davis
Total Awards:
56
Award Value:
$143,757,629
Major Facility Name:
Institute for Regenerative cures
Institution type:
Not for profit
Short Name:
UC Davis
Share
Awards to the Institution
Program
Investigator
Award Title
Award Value
Early Translational III
Walter Boyd
Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair
$4,631,754
Late Stage Preclinical Projects
Diana Farmer
Placental Mesenchymal Stem Cell Augmentation of Fetal Myelomeningocele Repair
$5,666,077
Preclinical Development Awards
Diana Farmer
Placental Stem Cells for the In Utero Treatment of Spina Bifida
$2,182,146
SEED Grant
Ebenezer Yamoah
Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells
$458,071
Disease Team Therapy Planning I
John Laird
Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia
$76,066
Patent Assistance Fund Awards
David McGee
CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies - UCD
$48,595
New Faculty Physician Scientist
Emanual Maverakis
Tunable hydrogels for therapeutic delivery of multipotent stem cells.
$2,772,000
Conference
Mark Yarborough
Stem Cell Research for Neurological Disorders: A Case Study in Ethical and Policy Issues in ALS Research
$1,020
Shared Labs
Alice Tarantal
UC Davis Translational Human Embryonic Stem Cell Shared Research Facility
$1,728,111
Early Translational III
Kyriacos Athanasiou
Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells
$1,735,703
Preclinical Development Awards
Roslyn Isseroff
Scaffold for dermal regeneration containing pre-conditioned mesenchymal stem cells to heal chronic diabetic wounds
$4,620,144
SEED Grant
A. Reddi
hESCs for Articular Cartilage Regeneration
$301,703
Disease Team Therapy Planning I
Vicki Wheelock
MSC engineered to produce BDNF for the treatment of Huntington's disease
$97,564
Quest - Discovery Stage Research Projects
Deborah Lieu
Microenvironment for hiPSC-derived pacemaking cardiomyocytes
$2,042,728
Disease Team Therapy Development III
Peter Belafsky
Tissue Engineered Recellularized Laryngotracheal Implants
$3,181,162
Conference
Alice Tarantal
11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
$16,850
Tools and Technologies I
Alice Tarantal
In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates
$799,350
Disease Team Therapy Development - Research
John Laird
Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia
$3,728,384
Clinical Trial Stage Projects
Mehrdad Abedi
Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients
$8,414,265
New Faculty II
Paul Knoepfler
Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency
$2,157,255
Disease Team Therapy Planning I
Mehrdad Abedi
Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients
$66,880
Alpha Stem Cell Clinics Network Expansion
Mehrdad Abedi
Alpha Stem Cell Clinic for Northern and Central California
$7,905,671
Major Facilities
Larry Vanderhoef
UC Davis CIRM Institute
$20,082,400
Basic Biology I
Min Zhao
Directing migration of human stem cells with electric fields
$816,228
Conference
Alice Tarantal
9th Annual Gene Therapy Symposium for Heart, Lung and Blood Diseases
$12,000
Tools and Technologies I
Kit Lam
Discovery of adhesion ligands for pluripotent human stem cells
$834,003
Disease Team Therapy Development - Research
Nancy Lane
Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells
$19,999,867
SPARK
Gerhard Bauer
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility
$388,645
Comprehensive Grant
Mark Zern
An in vitro and in vivo comparison among three different human hepatic stem cell populations.
$2,251,223
Disease Team Therapy Planning I
Nancy Lane
Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis
$107,750
Conference - Manage The SPARK Annual Meeting
Gerhard Bauer
The 2018 SPARK Annual Meeting
$39,988
Shared Labs
Alice Tarantal
UC Davis Translational Human Embryonic Stem Cell Shared Research Facility
$2,000,000
Basic Biology II
Eric Kurzrock
Differentiation of Human Embryonic Stem Cells into Urothelium
$849,037
Transplantation Immunology
William Murphy
Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance
$1,257,601
Conference
Alice Tarantal
10th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
$18,300
Disease Team Therapy Development - Research
Vicki Wheelock
MSC engineered to produce BDNF for the treatment of Huntington's disease
$8,924,235
Therapeutic Translational Research Projects
Joseph Anderson
Overexpression of HexA/HexB by lentivector expression in blood cells to treat Tay-Sachs and Sandhoff disease
$883,174
Comprehensive Grant
Alice Tarantal
Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells
$2,166,757
Disease Team Therapy Planning I
Martin Birchall
Airways for Children
$19,800
Inception - Discovery Stage Research Projects
Alyssa Panitch
Development of treatments to improve healing of ischemic wounds
$235,800
Tools and Technologies III
J. Leach
Multi-modal technology for non-destructive characterization of bioengineered tissues
$1,842,792
Early Translational II
Mark Zern
Liver Cell Transplantation
$4,212,621
New Faculty I
Chong-Xian Pan
Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells
$2,386,409
Conference
Alice Tarantal
13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
$10,000
Basic Biology IV
Deborah Lieu
Induction of Pluripotent Stem Cell-Derived Pacemaking Cells
$1,333,689
Quest - Discovery Stage Research Projects
David Segal
MSC delivery of an artificial transcription factor to the brain as a treatment for Angelman Syndrome
$1,087,572
Early Translational I
Jan Nolta
Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders
$2,615,674
Training Grant I-1
Frederick Meyers
Stem Cell Research Training Grant
$1,780,859
Inception - Discovery Stage Research Projects
Alice Tarantal
Enhanced Branching Morphogenesis and Pluripotent Cell Lineage Differentiation for Pediatric Regenerative Therapies
$235,800
Tools and Technologies III
Laura Marcu
Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs
$1,834,474
Early Translational II
Roslyn Isseroff
Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds
$4,629,747
Research Training II
Frederick Meyers
UC Davis Stem Cell Training Program
$4,838,291
Conference
Randi Hagerman
Pathways of Neurodevelopmental Disorders (C8)
$29,939
Creativity Awards
Gerhard Bauer
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility
$250,064
Conference
Alice Tarantal
12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases
$8,000
Early Translational I
Alice Tarantal
In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies
$3,143,392
Total:
$143,757,630.00